Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis

BACKGROUND: Direct oral anticoagulants (DOACs) have become widely used for the prevention of stroke in nonvalvular atrial fibrillation (AF) and for the treatment of venous thromboembolism (VTE). Warfarin, the standard of care prior to DOACs, requires monitoring and dose adjustment to ensure patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Karnick, Cameron, Modany, Ashley, McGraw, Molly, Ludwig, Justin, Marr, David, Hammonds, Tracy, Good, Chester B, Culley, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372967/
https://www.ncbi.nlm.nih.gov/pubmed/36282935
http://dx.doi.org/10.18553/jmcp.2022.28.11.1304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372967/
https://www.ncbi.nlm.nih.gov/pubmed/36282935
http://dx.doi.org/10.18553/jmcp.2022.28.11.1304

Ejemplares similares